injectable local formation depot formulation, process for preparing said formulation, pharmaceutical composition, pre-filled syringe, and use of peg500 dme
A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent.